在位于吉林通化医药高新区的建新科技有限公司智慧工厂的生产线上，为印尼某大型镍铁项目定制 的核心冶炼部件正加紧装配。公司财务负责人拿着建设银行通化市分行批复的3.5亿元综合授信函，对 下一步承接更大海外订单底气十足。这个从一个砖厂机修车间发展起来的"制造业单项冠军示范企业"、 国家级专精特新"小巨人"企业，是通化市唯一一家荣获两项国家级殊荣的企业，建行早在2019年开始就 持续为企业输血赋能，从2600万元的贷款到3.5亿元的综合授信，建行见证了建新科技的跨越式发展， 这同时也是通化市金融助力中小微企业发展的一个缩影。 通化有2/3面积是山区，也被称为"北国山城"。从长白山麓的特色种植养殖，到"中国医药城"的专 精特新，再到走向世界的装备制造，诸多中小微企业的创业故事，共同勾勒出通化经济脉动最生动的线 条。在这线条背后，一股强大而细腻的金融力量正如同松花江的支流，蜿蜒渗透，滋养万物。这股力量 的"引擎"正是来自中国人民银行通化市分行。近年来，该行以高度的政治自觉和使命担当，将"金融工 作的政治性、人民性"书写在服务实体经济的广阔田野和工厂车间，探索出一条富有通化特色的金融支 持中小微企业发展之路，助力这座城市在 ...

（原标题：向日葵重组预案 涉嫌误导性陈述被立案调查） 证券时报记者 程丹 1月14日，浙江证监局对浙江向日葵大健康科技股份有限公司重组预案涉嫌误导性陈述立案调查。证监 会表示，下一步将在全面调查的基础上依法处理，切实维护并购重组市场秩序。 2025年9月22日，向日葵披露重组预案。近期，重组标的的实际产能和业务模式引发市场质疑，浙江证 监局依法开展核查工作，发现重组预案涉嫌误导性陈述，已于近日对向日葵立案调查。 ...

2025年9月22日，向日葵披露重组预案。近期，重组标的的实际产能和业务模式引发市场质疑，浙江证 监局依法开展核查工作，发现重组预案涉嫌误导性陈述，已于近日对向日葵立案调查。 （文章来源：证券时报） 1月14日，浙江证监局对浙江向日葵大健康科技股份有限公司重组预案涉嫌误导性陈述立案调查。证监 会表示，下一步将在全面调查的基础上依法处理，切实维护并购重组市场秩序。 ...

Core Viewpoint - The article discusses the restructuring plan of Zhejiang Sunflower Health Technology Co., Ltd. (Sunflower), which has come under scrutiny due to misleading statements regarding its actual production capacity and business model, leading to an investigation by the Zhejiang Securities Regulatory Bureau [1][4]. Group 1: Restructuring Plan and Investigation - On September 22, 2025, Sunflower disclosed a restructuring plan involving the acquisition of 100% equity in Xipu Materials, a semiconductor company, and a 40% stake in Beid Pharmaceutical, along with raising supporting funds [4]. - The Zhejiang Securities Regulatory Bureau initiated an investigation after concerns were raised about the actual production capacity of Xipu Materials, which was previously reported to lack real production capabilities [4][5]. - The restructuring plan has been questioned for potentially containing misleading information, prompting a thorough investigation to maintain order in the mergers and acquisitions market [1]. Group 2: Market Reaction and Financial Performance - Following the announcement of the restructuring plan, Sunflower's stock price initially rose, reaching a peak of 10.28 CNY, but subsequently fell, closing at 6.2 CNY on January 14, 2026, representing a nearly 28% decline from its highest point [5]. - As of January 14, 2026, Sunflower's total market capitalization was reported at 8 billion CNY [5]. - The Shenzhen Stock Exchange issued a notice to Sunflower on December 26, 2025, requesting verification of Xipu Materials' production capacity and potential impacts on competition and independence due to the restructuring [5].

（来源：VCA创投社） 深创投集团是以创业投资为核心的国有综合性投资集团，以打造世界一流投资机构为己任，致力于做创 新价值的发掘者和培育者、中国创业投资事业的探路者和引领者。目前，该集团累计管理各类资产总规 模超5100亿元，业务涵盖风险投资、不动产投资、公募基金、资产证券化等，投资企业数量超1700家， 其中IPO退出287家。 在刚刚过去的2025年，深创投集团收获了15个IPO,其含金量同样令人瞩目——100%的硬科技企业，切 合其"国家需要什么，我们投什么"的理念。 | 芯城 | | 09-30 | 板 | 巨人 | | | --- | --- | --- | --- | --- | --- | | 劲方 | 02595.HK | 2025- | 港交 所主 | 专精特新小 | 专注开发肿瘤（涵盖多种实体瘤的不同治疗线）及自体免 | | 医药 | | 09-19 | | 巨人 | 疫和炎症性疾病领域新治疗方案 | | | | | 板 | | | | 志高 | 920101 | 2025- | 北交 | 专精特新小 | 专业从事凿岩设备和空气压缩机的研发、生产、销售和服 | | 机械 | | 08-14 ...

国家知识产权局信息显示，华润三九医药股份有限公司、深圳市中药制造业创新中心有限公司、华润三 九现代中药制药有限公司、华润三九（六安）中药材产业发展有限公司取得一项名为"一种千里香中化 学成分的分离方法和含量测定方法"的专利，授权公告号CN116953125B，申请日期为2023年8月。 天眼查资料显示，华润三九医药股份有限公司，成立于1999年，位于深圳市，是一家以从事医药制造业 为主的企业。企业注册资本128429.8685万人民币。通过天眼查大数据分析，华润三九医药股份有限公 司共对外投资了50家企业，参与招投标项目5000次，财产线索方面有商标信息2213条，专利信息582 条，此外企业还拥有行政许可336个。 深圳市中药制造业创新中心有限公司，成立于2021年，位于深圳市，是一家以从事研究和试验发展为主 的企业。企业注册资本8000万人民币。通过天眼查大数据分析，深圳市中药制造业创新中心有限公司参 与招投标项目181次，专利信息30条，此外企业还拥有行政许可7个。 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 来源：市场资讯 华润三九现代中药制药有限公司， ...

Group 1 - The core viewpoint of the news is that Dongyangguang's stock has experienced a significant increase, with a 35% rise over the past seven days, reaching a price of 30.28 yuan per share and a market capitalization of 911.29 billion yuan [1] - Dongyangguang Technology Holdings Co., Ltd. is based in Dongguan, Guangdong, and was established on October 24, 1996, with its listing date on September 17, 1993. The company operates in four main business segments: electronic new materials, alloy materials, chemical products, and pharmaceutical manufacturing [1] - The revenue composition of Dongyangguang's main business includes high-end aluminum foil at 40.81%, new chemical materials at 27.63%, electronic components at 25.40%, and other categories contributing 2.63% [1] Group 2 - From the perspective of fund holdings, Invesco Great Wall Fund has a significant position in Dongyangguang, with its "Invesco Great Wall Stable Pension Target Three-Year Holding Period Mixed Fund (FOF) A" holding 2,000 shares, representing 0.05% of the fund's net value [2] - The fund has generated a floating profit of approximately 740 yuan today, with a total floating profit of 15,700 yuan during the seven-day increase [2] - The fund was established on September 26, 2019, with a current scale of 72.67 million yuan, and has achieved a year-to-date return of 1.41%, ranking 763 out of 1,305 in its category [2]

Core Viewpoint - The Ministry of Justice has released a batch of typical cases to demonstrate the effective practices in administrative law enforcement related to enterprises, emphasizing the shift from passive regulation to proactive service and from post-event correction to pre-event prevention [1][4]. Group 1: Innovative Law Enforcement Mechanisms - Various regions have introduced efficient and collaborative new forms of law enforcement, such as the "on-site inspection" model in Heilongjiang, which reduces costs for enterprises by providing inspections at their locations [2][6]. - In Jilin, a strategy combining flexible law enforcement with source governance has been implemented to address the parking difficulties faced by large trucks, improving logistics efficiency and reducing costs for enterprises [3][9]. Group 2: Optimizing Service Supply - Local governments are proactively integrating resources to provide targeted guidance services to enterprises, helping them overcome technical, safety, and approval challenges, as seen in Shandong where a collaborative approach provided comprehensive safety guidance [2][12]. - In Ningxia, the approval process for fire safety checks has been streamlined, reducing the processing time from 13 days to 7 days, thus enhancing service efficiency while ensuring safety [3][14]. Group 3: Collaborative Precise Policies - In Henan, cross-departmental collaboration has optimized construction plans, ensuring projects are completed efficiently while benefiting enterprises and the public [3][16]. - Yunnan has effectively addressed malicious claims against small and medium enterprises through training and legal support, enhancing their ability to respond to such issues [3][20]. Group 4: Exploring New Law Enforcement Service Models - In Fujian, a "market day" joint inspection mechanism has been introduced to reduce the burden of multiple inspections on enterprises, significantly improving satisfaction rates [3][22]. - In Jiangxi, a random allocation system for market stalls has been implemented to ensure fair distribution among vendors, addressing complaints about unfair practices [3][26].

通报显示，2023年1月，海怡莱公司与上海泓健医药有限公司签订为期一年的信息服务协议，负责后者销售的"达肝素钠注射液"（商品名：万脉宁）在上海 地区的市场推广与信息服务工作，目标为维持并提升该药品销量。 海怡莱公司主要从事药品市场营销策划，其日常工作包括拜访相关企业与医疗机构、收集药品临床反馈、组织学术活动、进行医生拜访以及撰写市场分析报 告等。然而，为达成销量目标，该公司采取了不正当手段。2023年1月至12月期间，公司销售推广总监兼股东袁某某向上海市第一妇婴保健院生殖免疫科医 生顾某承诺，只要多开具万脉宁，即可获得相应"好处费"。调查证实，袁某某通过个人微信分四次向顾某转账，总额达35046元。在此期间，顾某累计开具 该药品18275支。 通过上述推广，海怡莱公司从泓健医药公司获得的服务收入合计868677元。上海普陀区市场监督管理局调查认定，该行为已构成商业贿赂，依法对海怡莱公 司作出罚款30万元的行政处罚。 经观健康 据经济观察报-经济观察网 国家医保局近日通报一起医药咨询服务企业涉嫌商业贿赂的典型案例。上海海怡莱企业咨询管理合伙企业（下称海怡莱公司）为 推广特定药品，向临床医生支付不正当利益，影响其 ...

上周，上证指数连续收阳并站上4100点，权益类FOF基金业绩较好，部分产品单周业绩超过6%。 值得注意的是，随着A股行情不断回暖，FOF基金的发行也在升温。而围绕"新年投什么"，医药生物行业近期再次被公募关注，这也是去年有所活跃但 整体估值依然有待修复的板块之一。沪指16连阳，股票型FOF最高收益率超6% 多只重仓科创主题基金以及相关ETF的产品在最近一周表现活跃，如工银睿智进取一年A，重仓的国泰中证半导体材料设备主题ETF、嘉实上证科创板 芯片ETF等最近一周的业绩超过10%。 上周，脑机接口概念走强，核心催化是马斯克宣布Neuralink公司将于2026年启动脑机接口设备的大规模生产，并推出几乎完全自动化的手术流程，降 低手术风险和成本。受此带动，相关概念股走势及基金的短期业绩强劲。 根据麦肯锡预测，全球脑机接口医疗应用市场规模有望在2030年达到400亿美元，2040年达到1450亿美元。其中，以中枢神经系统疾病治疗为主的市场 规模2030年预计为150亿美元，2040年为850亿美元。 该行情是否可持续？长城消费增值基金经理龙宇飞表示，脑机接口是我国十五五规划明确支持的未来产业之一，也是全球科技巨头非 ...